Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This study addresses, whether treatment with IV iron for patients with heart failure with
preserved ejection fraction (HFpEF) and iron deficiency (ID), both with or without anaemia,
can improve exercise capacity as measured by 6-minute walking test (6-MWT) and symptoms while
being safe